515 Results
Guidelines and Advice
Status: Current
Dec 1969
Guidelines and Advice
Status: Current
ID: GL-C50-24
Version: 3
ID: GL-C50-24
Version: 3
Jan 2024
Guidelines and Advice
Status: Current
ID: GL-C50-32
ID: GL-C50-32
Jan 2021
Symptom Management
Symptom Management
Symptom Management
Drug
Dec 1969
Drug
Jan 2025
Drug
Dec 1969
Drug
Other Name(s): Oncovin® (multiple brands available)
Nov 2017
Drug
Other Name(s): Neulasta®, Lapelga®, Fulphila™; Ziextenzo®; Nyvepria™, Niopeg®, Pexegra™
Dec 1969